AstraZeneca erwägt Abspaltung des China-Geschäfts
Pharma - Der britisch-schwedische Arzneimittelhersteller AstraZeneca erwägt einem Zeitungsbericht zufolge eine Abspaltung seines China-Geschäfts....…
78,979$
0,51%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca Reportedly Weighs Spin-off for CN Biz with Potential HK IPO
Pharmaceutical firm AstraZeneca is drafting a plan to spin off its China business and may pursue a separate listing for…
AstraZeneca Drafts Plan to Spin Off China Business, FT Says
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca planning China business spin off -FT
...(Reuters) - Drugmaker AstraZeneca is drafting a plan to spin off......…
Astrazeneca (AZN) Gains But Lags Market: What You Should Know
Astrazeneca (AZN) closed the most recent trading day at $74.13, moving +0.38% from the previous trading session....…
AstraZeneca (AZN) Breast Cancer Combo Drug Gets Priority Review
The FDA grants priority review status to AstraZenecas (AZN) capivasertib/Faslodex combination for the treatment of adult patients with HR-positive, HER2-negative…
AstraZeneca to decarbonize U.S. footprint by turning cow manure into renewable natural gas
In a first for the pharma sector, AstraZeneca will tap renewable natural gas for its U.S. manufacturing sites by the…
AstraZeneca Partners Vanguard Renewables To Use Renewable Natural Gas In The U.S. By End Of 2026
LONDON (dpa-AFX) - In a first-of-its-kind collaboration, British drug major AstraZeneca plc (AZN, AZN.L) is partnering with Vanguard Renewables to…
Vanguard Renewables Announces Innovative Partnership With AstraZeneca to Decarbonize United States Medicines Manufacturing
Agreement will deliver renewable natural gas to U.S. research and manufacturing sites, starting in Newark, Delaware, and accelerate progress on…
AstraZeneca turns to cows to cut U.S. carbon footprint
...By Natalie Grover
LONDON (Reuters) - Drugmaker AstraZeneca......…
AstraZeneca wins approval in China for Soliris in myasthenia gravis
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Astrazeneca erhält in China Zulassung für Soliris
Von Joe Hoppe LONDON (Dow Jones)--Astrazeneca hat in China die Zulassung für das Medikament Soliris (Eculizumab) für Erwachsene zur…
BRIEF-Soliris Approved In China For The Treatment Of Adults With Refractory Generalised Myasthenia Gravis, 13 June 2023
...June 13 (Reuters) - AstraZeneca PLC:
* SOLIRIS APPROVED IN CHINA......…
Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know
Astrazeneca (AZN) closed the most recent trading day at $73.85, moving -0.28% from the previous trading session....…
AstraZeneca (AZN) & Quell to Co-Develop Autoimmune Cell Therapies
AstraZeneca (AZN) enters into a collaboration agreement with Quell Therapeutics to co-develop novel cell therapy options in major autoimmune indications…
AstraZeneca breast cancer drug capivasertib gets priority review in US
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca in deal with start-up to fight diabetes
The FTSE 100 firm will team up with London-based Quell Therapeutics to collaborate on research and the licensing of any…
AstraZeneca in pact with Quell Therapeutics for Treg cell therapies
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K ASTRAZENECA PLC For: Jun 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
TOP NEWS: AstraZeneca hails deal with Quell; positive danicopan data
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca places $85 million bet on autoimmune cell therapy with ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca signs $2 bln agreement with Quell to develop cell therapies
...June 9 (Reuters) - AstraZeneca said on Friday it
had signed......…
AstraZeneca signs $2 billion agreement with Quell to develop cell therapies
...(Reuters) - AstraZeneca said on Friday it had signed an agreement......…
AstraZeneca places US$85mln bet on autoimmune cell therapy with ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
BRIEF-Astrazeneca Says Results From Alpha Phase III Trial Demonstrated Statistically Increase In Haemoglobin
...June 9 (Reuters) - AstraZeneca PLC:
* ASTRAZENECA - DANICOPAN AS ADD......…
FDA-Ausschuss empfiehlt Nirsevimab zur RSV-Prävention bei Kleinkindern
Von Joe Hoppe LONDON (Dow Jones)--Der von den Pharmakonzernen Astrazeneca und Sanofi gemeinsam entwickelte Antikörper Nirsevimab ist von einem…
AstraZeneca: FDA Committee Recommends Nirsevimab For RSV Lower Respiratory Tract Disease In Infants
LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN, AZN.L) announced Friday that the US Food and Drug Administration Antimicrobial…
Astrazeneca schließt mit Quell Vereinbarung über Treg-Zell-Therapien
Von Anthony O. Goriainoff LONDON (Dow Jones)--Astrazeneca hat mit Quell Therapeutics eine Zusammenarbeit bei der Entwicklung, Herstellung und Vermarktung…
Syncona: Quell Signs Cell Therapy Deal With AstraZeneca Focused On Autoimmune Diseases
LONDON (dpa-AFX) - Healthcare investment company Syncona Limited (SYNC.L) announced Friday that Quell Therapeutics, a developer of engineered T-regulatory (Treg)…
AstraZeneca Says Nirsevimab Recommended for RSV Prevention in Infants by FDA Body
AstraZeneca Says Nirsevimab Recommended for RSV Prevention in Infants by FDA Body...…
BUSINESS LIVE: North Sea windfall tax to be reformed
Among the companies with reports and trading updates today are Mothercare, CMC Markets, Croda International, AstraZeneca, S4 Capital and MP…
AstraZeneca Reaches Agreement With Quell Therapeutics for Treg Cell Therapies
AstraZeneca Reaches Agreement With Quell Therapeutics for Treg Cell Therapies...…
AstraZeneca hails RSV drug nirsevimab recommendation by FDA committee
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
nirsevimab recommended for infant RSV protection
9 June 2023
Nirsevimab unanimously recommended by FDA Advisory Committee for the
prevention of RSV lower respiratory tract disease in infants
If approved,…
AstraZeneca agreement with Quell Therapeutics
09 June 2023
AstraZeneca announces agreement with Quell Therapeutics
to develop, manufacture and commercialise
engineered T-regulatory cell therapies for autoimmune diseases
Collaboration focused on…
AstraZeneca, Sanofi win FDA advisory committee backing for RSV therapy nirsevimab
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Infant RSV Drug From Sanofi, AstraZeneca Wins Backing of Key ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
FDA advisers vote in favor of AstraZeneca, Sanofi antibody for infant RSV protection
Advisers to the U.S. Food and Drug Administration voted unanimously Thursday to recommend a monoclonal antibody developed by Sanofi SNY…
FDA advisors recommend AstraZeneca antibody to protect babies from RSV
If the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that…
AstraZeneca: Broker upbeat after American cancer conference data ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca and Daiichi Sankyo report progress in cancer drug trials
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca (AZN) Anticoagulant Drug Study Meets Efficacy Goal
At the interim analysis, AstraZenecas (AZN) drug Andexxa showed superior hemostatic efficacy or in other words improved control of bleeding…
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....…
AstraZeneca Reports Positive Results From Interim Analysis Of DESTINY-PanTumor02 Phase II Trial
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L, AZN) and Daiichi Sankyos Enhertu showed an objective response rate of 37.1% in the…
AstraZeneca Neutral
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Neutral" mit einem Kursziel von 12500…
AstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in Trial
AstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in Trial...…
AstraZeneca stops Andexxa trial early, Tagrisso reduces death risk
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Says Andexxa Phase IV Trial Stopped Early On Achieving Efficacy Goal
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L) on Monday said the Phase 4 study of Andexxa in patients on oral FXa-inhibitor…
Lung cancer pill cuts risk of death by half, study finds
The drug, developed by AstraZeneca, if taken daily after surgery, dramatically reduces risk of death, study shows....…
AstraZeneca to Stop Intracranial Hemorrhage Drug Trial After Criteria Met
AstraZeneca to Stop Intracranial Hemorrhage Drug Trial After Criteria Met...…